Vantage Point Financial’s Merck MRK Stock Holding History

Vantage Point Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$330K	Buy	2,741 +157	+6%	+$18.1K	0.12%	119
2025 Q4	$272K	Buy	+2,584	New	+$243K	0.1%	134

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vantage Point Financial's MRK Position: Q1 2026 in Review

Vantage Point Financial increased its Merck (MRK) stake by 6.1% in Q1 2026, buying an estimated $18.1K and bringing the position to 2,741 shares worth $330K. The position accounts for 0.12% of the portfolio, ranked #119.

Vantage Point Financial first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Vantage Point Financial held 2,741 shares of Merck worth $330K as of Q1 2026.
Vantage Point Financial bought 157 Merck shares in Q1 2026, an estimated $18.1K.
Merck made up 0.12% of Vantage Point Financial's portfolio in Q1 2026, its #119 holding.
Vantage Point Financial first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Vantage Point Financial's 13F filing for Q1 2026, filed 4 May 2026.